Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection.
The current treatment paradigm in Clostridium difficile infection is the administration of antibiotics contributing to the high rates of recurrent infections. Recent alternative strategies, such as fecal microbiome transplantation and anti-toxin antibodies, have shown similar efficacy in the treatme...
| Publicado en: | Artificial Intelligence in Medicine Vol. 78; pp. 1 - 14 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
Elsevier B.V.
May2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |